We are proud to announce that Corneal Collagen Crosslinking (CXL) will now be offered at Eye Specialty Group. CXL is a relatively new medical procedure for a progressive eye disease called keratoconus. The Corneal cross-linking technique uses UV light and a photosensitizer to strengthen chemical bonds in the cornea, thereby halting the progression of keratoconus.
An independent Institutional Review Board-approved study is now open to enroll patients to participate.
For more information or to see if you may be a participant, please contact Michael Sanford, email: email@example.com